Clarivate Analytics Joins Accenture's Life Sciences Ecosystem to Help Accelerate Innovation in Drug Discovery and Scientific Research
January 10, 2019 at 03:00 am
Share
Clarivate Analytics, has joined Accenture's open partner ecosystem, which is designed to help independent software vendors (ISVs), specialized content providers, and life sciences companies team more effectively to advance drug discovery efforts and improve patient outcomes. The ecosystem is an integral part of Accenture's cloud-based informatics research platform, which helps life sciences organizations improve productivity, efficiency and innovation in drug discovery. Clarivate is working with Accenture to integrate its content into Accenture's research platform and provide access to more robust insights that enable data-driven decision-making. The data and intelligence provided by Cortellis, the life sciences suite of solutions from Clarivate, will be accessible to companies within a common informatics framework that addresses core infrastructure requirements such as data ingestion and cleansing, security and IP management, request management workflow, enterprise search, data governance, and collaboration environments. The scientifically-curated content in Cortellis includes more than 600,000 compounds, 2.3 million biological pathways and effects, comprehensive experimental results, clinical trial outcomes, and biomarkers intelligence. These rich data sets provide critical context for researchers and complement the data they generate in support of clinical research, regulatory, manufacturing, marketing and portfolio strategy needs.
Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company provides research and analytics, content aggregation, and workflow software solutions. Within the IP segment, the Company provides IP Maintenance, IP Intelligence, and IP Management solutions. Within the LS&H segment, the Company provides research and development, regulatory and safety, and commercialization solutions. It is also a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. It serves a large, diverse, and global customer base across the scientific research, intellectual property, and life sciences and healthcare end markets. Its customers include corporations, universities, law firms, and others.